Coronado Biosciences Inc. (CNDO): CFO Lucy Lu Bought 4,545 Shares
CFO of Coronado Biosciences Inc. (CNDO) Lucy Lu bought 4,545 shares on 07/17/2013 at an average price of $7.9.
Coronado Biosciences Inc. is a biopharmaceutical company, engaged in the development of novel immunotherapy agents for cancer and inflammatory diseases. Coronado Biosciences Inc. has a market cap of $231.398 million; its shares were traded at around $8.21 .
On May 8, 2013, Coronado Biosciences Inc. (CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today its financial results for the first quarter. Coronado reported a net loss of $8.9 million, or $0.35 per share, for the first quarter of 2013 compared to a net loss of $6.6 million, or $0.35 per share, for the first quarter of 2012.
Executive VP and COO Noah D. Beerman bought 5,000 shares of CNDO stock on 05/31/2013 at the average price of $3.88. Noah D. Beerman owns at least 15,000 shares after this.
For the complete list of stocks that were bought by their CFOs, go to: Insider Buys.